Biotech · Private company
Charleston Laboratories, Inc
Track this companyFree. Adds Charleston Laboratories, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- CL-108 5 mgPhase 3 · PainClinicalTrials.gov · fetched Nov 12, 2026
- NorcoPhase 3 · PainClinicalTrials.gov · fetched Nov 12, 2026
- Arm 1: CL-H1TPhase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Arm 2: CL-H1TPhase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Arm 3: Sumatriptan Succinate 100 mg capsulePhase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Arm 4: Promethazine HCl 18.75 mgPhase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Arm 5: Promethazine HCl 37.5 mgPhase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine PainPHASE2 · COMPLETED · started Feb 1, 2019ClinicalTrials.gov NCT03877718 · fetched Nov 12, 2026
- A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINVPHASE3 · COMPLETED · started Aug 2, 2017ClinicalTrials.gov NCT03657810 · fetched Nov 12, 2026